Safety and Efficacy of ThisCART19 in Patients With Refractory or Relapsed B Cell Malignancies
Clinical trial NCT04384393 · UNKNOWN
Trial details
- NCT number
- NCT04384393
- Sponsor
- Fundamenta Therapeutics, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-09
- Primary completion
- 2022-11-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.